SCHEMBL3546351

SCHEMBL3546351

O=Cc1ccc2c(n1)C(=O)C=CC2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 2/20 0.55
CCR1 P32246 1/20 0.43
CDC25B P30305 2/20 0.42
ALDH1A1 P00352 2/20 0.35
IDO1 P14902 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
AKT1 P31749 1/20 0.34
SNCA P37840 1/20 0.34
MAP2K1 Q02750 1/20 0.34
PIN1 Q13526 1/20 0.34
EHMT2 Q96KQ7 1/20 0.34
NSD1 Q96L73 1/20 0.34
EHMT1 Q9H9B1 1/20 0.34
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11358184 0.71 S100A4 (0.59) S100A4CDC25BALDH1A1IDO1MAOA
SCHEMBL28289103 0.71 S100A4 (0.59) S100A4CDC25BALDH1A1IDO1MAOA
SCHEMBL2599222 0.71 S100A4 (1.00) S100A4CCR1CDC25BALDH1A1IDO1
SCHEMBL3657123 0.70 HDAC6 (0.50) S100A4ALDH1A1MAOBLMNAHPGD
SCHEMBL3657118 0.70 HDAC6 (0.50) S100A4ALDH1A1MAOBLMNAHPGD
SCHEMBL6412872 0.67 S100A4 (0.58) S100A4CDC25BALDH1A1IDO1MAOA
SCHEMBL2830315 0.67 CCR1 (0.42) CCR1ALDH1A1MEN1LMNAHPGD
SCHEMBL9301644 0.65 S100A4 (0.48) S100A4CCR1MAOBCYP1A2MAPK1
SCHEMBL6375662 0.62 PADI1 (0.62) S100A4CCR1CDC25BALDH1A1IDO1
SCHEMBL5800358 0.62 MAPT (0.53) S100A4CDC25BALDH1A1IDO1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807668-B2 Anti-inflammatory compounds NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED (NZ) 2010-10-05 US disclosed
US-20070265253-A1 Anti-Inflammatory Compounds NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED (NZ) 2007-11-15 US disclosed
EP-1789422-A1 ANTI-INFLAMMATORY COMPOUNDS NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED (NZ) 2007-05-30 EP disclosed
WO-2006031134-A1 ANTI-INFLAMMATORY COMPOUNDS NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED (NZ) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265253-A1 Anti-Inflammatory Compounds TNF, PTGS1, PTGES S100A4 64/4885CCR1 238/4885CDC25B 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.